-+ 0.00%
-+ 0.00%
-+ 0.00%

Rentokil expects full-year performance in line with market expectations

PUBT·04/16/2026 11:08:53
Listen to the news
Rentokil expects full-year performance in line with market expectations
  • Rentokil Initial kept full-year 2026 performance outlook unchanged, targeting results in line with market expectations.
  • Q1 revenue rose 4.3% to USD 1.68 billion; organic revenue growth was 3.4%.
  • North America revenue increased 4.5% to USD 995 million; organic revenue growth was 3.9%.
  • International revenue grew 4.1% to USD 682 million; organic revenue growth was 2.8%.
  • Bolt-on M&A continued with 9 deals, adding USD 19 million of annualized revenue based on pre-acquisition results.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rentokil Initial plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001654954-26-003571), on April 16, 2026, and is solely responsible for the information contained therein.